Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.55% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
NeoGenomics
NEO
$2.28B
| $19.8M | ﹤0.01% |
2,674,335
+225,588
| +9% | +$2.37M |
2016 Q4
37 quarters
|
|
1977
Vital Farms
VITL
$383M
| $19.8M | ﹤0.01% |
1,405,032
+447,728
| +47% | +$10.6M |
2021 Q4
17 quarters
|
|
1978
BioLife Solutions
BLFS
$1.8B
| $19.8M | ﹤0.01% |
1,035,757
+10,587
| +1% | +$234K |
2020 Q1
24 quarters
|
|
1979
Atlas Energy Solutions
AESI
$1.46B
| $19.7M | ﹤0.01% |
1,502,480
+167,758
| +13% | +$1.96M |
2024 Q2
7 quarters
|
|
1980
Kodak
KODK
$964M
| $19.7M | ﹤0.01% |
2,177,801
+113,398
| +5% | +$865K |
2023 Q2
11 quarters
|
|
1981
Kosmos Energy
KOS
$1.54B
| $19.7M | ﹤0.01% |
7,083,075
+1,204,789
| +20% | +$2.26M |
2013 Q2
51 quarters
|
|
|
CVGW
1982
DELISTED
Calavo Growers
CVGW
| $19.6M | ﹤0.01% |
761,201
+60,152
| +9% | +$1.51M |
2013 Q2
51 quarters
|
|
|
CWBC
1983
Community West Bancshares
CWBC
$712M
| $19.6M | ﹤0.01% |
840,454
+38,044
| +5% | +$890K |
2024 Q2
7 quarters
|
|
1984
Rocky Brands
RCKY
$345M
| $19.6M | ﹤0.01% |
505,479
-1,783
| -0.4% | -$64.9K |
2013 Q2
51 quarters
|
|
1985
Organon & Co
OGN
$3.6B
| $19.6M | ﹤0.01% |
3,265,280
-118,860
| -4% | -$894K |
2021 Q2
19 quarters
|
|
1986
Legacy Housing
LEGH
$694M
| $19.5M | ﹤0.01% |
955,771
+62,224
| +7% | +$1.3M |
2021 Q1
20 quarters
|
|
1987
Douglas Emmett
DEI
$1.63B
| $19.5M | ﹤0.01% |
2,070,960
-302,691
| -13% | -$3.11M |
2013 Q2
51 quarters
|
|
1988
Mobileye
MBLY
$6.25B
| $19.5M | ﹤0.01% |
2,838,520
-138,367
| -5% | -$1.25M |
2024 Q4
5 quarters
|
|
1989
Bausch Health
BHC
$2.14B
| $19.5M | ﹤0.01% |
3,604,818
+350,823
| +11% | +$2.1M |
2013 Q2
51 quarters
|
|
1990
Columbus McKinnon
CMCO
$460M
| $19.5M | ﹤0.01% |
1,339,044
-28,149
| -2% | -$525K |
2013 Q2
51 quarters
|
|
1991
Hovnanian Enterprises
HOV
$685M
| $19.4M | ﹤0.01% |
175,360
+174
| +0.1% | +$20.3K |
2021 Q1
20 quarters
|
|
1992
STRATTEC Security
STRT
$262M
| $19.4M | ﹤0.01% |
248,136
+8,542
| +4% | +$700K |
2013 Q2
51 quarters
|
|
1993
Granite Ridge Resources
GRNT
$580M
| $19.4M | ﹤0.01% |
3,306,999
+448,066
| +16% | +$2.25M |
2024 Q2
7 quarters
|
|
|
LEG
1994
DELISTED
Leggett & Platt
LEG
| $19.4M | ﹤0.01% |
1,958,653
-57,866
| -3% | -$661K |
2013 Q2
51 quarters
|
|
1995
Foster
FSTR
$382M
| $19.3M | ﹤0.01% |
693,492
-1,507
| -0.2% | -$44.5K |
2013 Q2
51 quarters
|
|
1996
Axogen
AXGN
$2.34B
| $19.3M | ﹤0.01% |
583,190
-18,602
| -3% | -$605K |
2019 Q2
27 quarters
|
|
1997
Barrett Business Services
BBSI
$759M
| $19.3M | ﹤0.01% |
661,181
+25,221
| +4% | +$833K |
2013 Q2
51 quarters
|
|
1998
Transcat
TRNS
$844M
| $19.2M | ﹤0.01% |
262,033
+9,266
| +4% | +$652K |
2013 Q2
51 quarters
|
|
1999
Beazer Homes USA
BZH
$891M
| $19.2M | ﹤0.01% |
999,804
+51,284
| +5% | +$1.18M |
2013 Q2
51 quarters
|
|
2000
Hyster-Yale Materials Handling
HY
$545M
| $19.1M | ﹤0.01% |
587,683
+28,642
| +5% | +$983K |
2013 Q2
51 quarters
|
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.